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We have shown previously that exposure of a non-transformed continuous line of rat liver epithelial (WB) cells to
epidermal growth factor (EGF), adrenaline, angiotensin II or [Arg8]vasopressin results in an accumulation of the inositol
phosphates InsPj, InsP2 and InsP3 [Hepler, Earp & Harden (1988) J. Biol. Chem. 263, 7610-7619]. Studies were carried
out with WB cells to determine whether the EGF receptor and other, non-tyrosine kinase, hormone receptors stimulate
phosphoinositide hydrolysis by common, overlapping or separate pathways. The time courses for accumulation of inositol
phosphates in response to angiotensin II and EGF were markedly different. Whereas angiotensin II stimulated a very
rapid accumulation of inositol phosphates (maximal by 30 s), increases in the levels of inositol phosphates in response to
EGF were measurable only following a 30 s lag period; maximal levels were attained by 7-8 min. Chelation of
extracellular Ca2+ with EGTA did not modify this relative difference between angiotensin II and EGF in the time required
to attain maximal phospholipase C activation. Under experimental conditions in which agonist-induced desensitization
no longer occurred in these cells, the inositol phosphate responses to EGF and angiotensin II were additive, whereas those
to angiotensin II and [Arg8]vasopressin were not additive. In crude WB lysates, angiotensin II, [Arg8]vasopressin and
adrenaline each stimulated inositol phosphate formation in a guanine-nucleotide-dependent manner. In contrast, EGF
failed to stimulate inositol phosphate formation in WB lysates in the presence or absence of guanosine 5'-[y-
thio]triphosphate (GTP[S]), even though EGF retained the capacity to bind to and stimulate tyrosine phosphorylation of
its own receptor. Pertussis toxin, at concentrations that fully ADP-ribosylate and functionally inactivate the inhibitory
guanine-nucleotide regulatory protein of adenylate cyclase (G1), had no effect on the capacity of EGF or hormones to
stimulate inositol phosphate accumulation. In intact WB cells, the capacity of EGF, but not angiotensin II, to stimulate
inositol phosphate accumulation was correlated with its capacity to stimulate tyrosine phosphorylation of the 148 kDa
isoenzyme of phospholipase C. Taken together, these findings suggest that, whereas angiotensin II, [Arg8]vasopressin and
ac-adrenergic receptors are linked to activation of one or more phospholipase(s) C by an unidentified G-protein(s), the
EGF receptor stimulates phosphoinositide hydrolysis by a different pathway, perhaps as a result of its capacity to
stimulate tyrosine phosphorylation of phospholipase C-y.
INTRODUCTION
The physiological actions of a large class of hormones and
neurotransmitters can be explained, in part, by their capacity to
activate plasma-membrane-associated phosphoinositidases (i.e.
phospholipase C) in target tissues (Downes & Michell, 1985;
Berridge, 1987). Activation of phospholipase C by cell surface
receptors results in hydrolysis of phosphatidylinositol 4,5-
bisphosphate to form two second messengers, Ins(1,4,5)P3 and
sn-1,2-diacylglycerol. Ins(1,4,5)P3 releases Ca2+ from intracellular
stores, whereas diacylglycerol activates protein kinase C; both
cytosolic Ca2+ and protein kinase C now are recognized to be
important regulators of cell function (Kikkawa & Nishizuka,
1986; Berridge, 1987). More recently, it has been demonstrated
that activation of receptors for mitogenic peptides including
epidermal growth factor (EGF) and platelet-derived growth
factor (PDGF) also results in stimulation of phospholipase C
activity in target tissues (Berridge et al., 1984; Pike & Eakes,
1987; Hepler et al., 1987; Johnson & Garrison, 1987; Tilly et al.,
1988; Tilly & Moolenaar, 1989; Wahl et al., 1988).
Although recent findings have contributed significantly to the
understanding of the biochemical events that occur subsequent
to hormone-stimulated formation of Ins(1,4,5)P3 and
diacylglycerol, much less is known about the events that underlie
receptor-effector coupling and activation of phospholipase C.
Increasing evidence strongly suggests that many receptors for
hormones and neurotransmitters are linked to activation of
phospholipase C by one or more as yet unidentified guanine-
nucleotide-binding regulatory proteins (G-proteins) (Litosch
et al., 1985; Cockcroft & Gomperts, 1985; Martin, 1989; Harden,
1989). In contrast, the mechanism whereby stimulation ofgrowth
factor receptors serves to regulate phospholipase C activity is not
known, although this topic has been the subject of intense study
(Paris et al., 1988; Blakeley et al., 1989; Tilly & Moolenaar,
1989). Receptors for EGF and PDGF are different from other
hormone receptors linked to phosphoinositide hydrolysis in that
they possess intrinsic tyrosine-specific protein kinase activity
(Carpenter, 1987; Yarden & Ullrich, 1988) and share little or no
amino acid sequence similarity or predicted structure with the
closely related 'superfamily' of G-protein-linked receptors
Vol. 270
337
Abbreviations used: EGF, epidermal growth factor; PDGF, platelet-derived growth factor; G-protein, guanine-nucleotide-binding regulatory
protein; GTP[S], guanosine 5'-[y-thioltriphosphate; GDP[S], guanosine 5'-[fi-thio]diphosphate; Gpp[NH]p, guanosine 5'-[fly-imidoltriphosphate;
PMA, phorbol 12-myristate 13-acetate; PMSF, phenylmethanesulphonyl fluoride.
¶ To whom all correspondence should be addressed.
J. R. Hepler and others
(O'Dowd et al., 1989). Previous findings are consistent with the
idea that PDGF may stimulate phosphoinositide hydrolysis in
fibroblasts by a mechanism that is different from that utilized by
hormones such as bombesin (Blakeley et al., 1989; Cattaneo &
Vincentini, 1989). Furthermore, recent reports demonstrate that
a 148 kDa isoenzyme of phospholipase C, i.e. phospholipase
C-y (Rhee et al., 1989), serves as a substrate in vitro as well as
in vivo for the tyrosine kinase activity associated with both the
EGF and the PDGF receptors (Wahl et al., 1989a,b; Nishibe
et al., 1989; Meisenhelder et al., 1989). These observations raise
the possibility that receptors for EGF may stimulate phospho-
inositide hydrolysis by a mechanism that is different from that of
other hormone receptors. To test this idea, studies were carried
out on a non-transformed continuous line of rat liver epithelial
cells (WB cells) to determine whether EGF and other hormones
stimulate phosphoinositide hydrolysis by common, overlapping
or independent pathways. We report findings consistent with the




EGF was prepared from mouse submaxillary glands as pre-
viously described (Savage & Cohen, 1972). Angiotensin II,
[Arg8]vasopressin and GTP[S] were obtained from Boehringer
Mannheim; adrenaline phorbol 12-myristate 13-acetate and
forskolin were obtained from Sigma. myo-[3H]Inositol
(15 Ci/mmol) was obtained from American Radiolabelled
Chemical Co. (St. Louis, MO, U.S.A.). Pertussis toxin was
purchased from List Biologicals. Anti-(phospholipase C-y) anti-
bodies were prepared as previously described (Suh et al., 1988).
Cell culture
WB cells were grown as previously described (Tsao et al.,
1984) with minor modifications (Hepler et al., 1988). Briefly, WB
stocks were maintained at 37 °C in an 8% CO2 humidified
atmosphere in Richter's improved minimal essential medium
containing insulin (4 mg/ml) and L-glutamine (Irvine Scientific,
Santa Ana, CA, U.S.A.) supplemented with 5 % fetal calf serum
and antibiotics. All stock plates were confluent and 5-7 days old
at the time of subculture. Subculture was accomplished by
aspirating the medium and detaching the cells by addition of I ml
of trypsin (0.25 %) in iso-osmotic citrate buffer (pH 7.4) for
15-30 min. Cells were seeded at 1:50 dilution, and for most
experiments cells were routinely grown on 6-well plastic culture
dishes (Costar).
Measurement of inositol phosphates in intact WB cells
WB cells were labelled with myo-[3H]inositol and assayed for
stimulated accumulation of [3H]inositol phosphates as described
previously (Hepler et al., 1988).
Measurement of inositol phosphates in WB lysates
WB cells were rinsed once with iso-osmotic buffer (0.9%
NaCl, 1 mM-EDTA, 10 mM-Hepes, pH 7.0) and were then col-
lected at 4°C in the same buffer containing a cocktail of
proteinase inhibitors including leupeptin (0.5 ,ug/ml), pepstatin
A (0.7 jug/ml), aprotinin (0.5 ,ug/ml), phenylmethanesulphonyl
fluoride (PMSF) (0.1 mM) and benzamidine (0.1 mM); PMSF
was freshly prepared in propan-2-ol and added to the lysis buffer
immediately before preparation of lysates. Cell suspensions were
homogenized by ten strokes in a ground glass homogenizer at
4 OC. Under these conditions more than 90% of the WB cells
were lysed as determined by Trypan Blue exclusion under
microscopic examination. Assays were initiated by addition of
50 ,l of lysates to an intracellular-like assay buffer (Harden et al.,
1987); the final assay volume was 200 1l. Incubations were
carried out at 37 °C and the reactions were stopped by addition
of 0.5 ml of ice-cold HC104 (6.25 %, v/v). The acid-inactivated
samples were centrifuged for 5 min, and supernatants were
collected and neutralized (Harden et al., 1987). Measurement of
VH]inositol phosphates was achieved by anion-exchange
chromatography as described above.
Measurement of adenylate cyclase activity
Assays to measure guanine-nucleotide-mediated inhibition of
forskolin-stimulated adenylate cyclase activity in broken cell
preparations were performed as previously described (Harden
et al., 1982).
Measurement of pertussis toxin-catalysed ADP-ribosylation of
WB membranes
WB cells were pretreated overnight with normal culture
medium in either the presence or the absence of the indicated
concentrations of pertussis toxin (0-300 ng/ml). Washed
membranes were prepared from control and toxin-treated cells.
ADP-ribosylation reactions, SDS/PAGE and autoradiography
were carried out as previously described (Martin et al., 1985).
Immunoprecipitation and measurement of tyrosine
phosphorylation of phospholipase C
WB cells were grown in 60 mm diameter plastic dishes.
Following treatment with hormone or growth factor, incubations
were terminated by rapid aspiration of the medium and addition
(1 ml per dish) ofice-cold lysis buffer containing 20 mM-NaHepes,
50 mM-NaF, 10% (v/v) glycerol, 1 % (w/v) Triton X-100, 1 mM-
sodium orthovanadate, 10 ,ug of PMSF/ml and 2.5 mm-p-
nitrophenylphosphate (Wahl et al., 1989a). Lysates were clarified
by centrifugation (12000 g; 10 min; 4 C). Phospholipase C-y
was immunoprecipitated by incubation with monoclonal anti-
(phospholipase C-y) antibodies (0.5,ug/tube), 5 ug of rabbit
anti-(mouse IgG) and 10 jul of Pansorbin (Calbiochem). After 4 h
at 4°C, immunoprecipitates were collected by centrifugation
(12000 g, 10 min) and the pellets were washed once (1 ml/tube)
with lysis buffer. For assays using WB lysates, cells were first
prepared as lysates as described above and were treated with
vehicle, angiotensin II or EGF in the presence or absence of
GTP[S] following the same protocol and using the same assay
buffers as described above for measuring inositol phosphate
formation in WB lysates. Reactions were terminated by addition
of 900 jul of lysis buffer to 200 jul of reaction mix. Solubilized
extracts then were clarified and immunoprecipitated as described
above. This procedure was found to precipitate all detectable (i.e.
immunoreactive) phospholipase C-y from WB cell extracts.
Immunoprecipitated proteins were solubilized for SDS/PAGE
on 7 % polyacrylamide gels, transferred to nitrocellulose
membranes and then subjected to anti-phosphotyrosine
immunoblotting and autoradiography as described (McCune &
Earp, 1989). [P-Tyr]Phospholipase C-y was located on
immunoblots by its apparent molecular mass and by co-migration
with the unique immunoreactive species (- 150 kDa) identified
by immunoblotting with monospecific anti-(phospholipase C-y)
antibodies. Evidence that the 170-180 kDa band is the EGF
receptor was provided by the fact that pre-clearing of the
solubilized cell lysates with anti-(EGF receptor) antisera (ab
1382) before immunoprecipitation with anti-phospholipase-y)
antibodies resulted in a selective loss of the 170 kDa band
(Huckle et al., 1990).
Statistical analysis
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Fig. 1. Time course for accumulation of inositol phosphates in response to
angiotensin II(i)or EGF (i)
WB cells were labelled overnight with 10 1sCi of [3H]inositol/ml in
inositol-free medium containing 5 % fetal calf serum. Following
labelling, cells were treated with 300 ng of EGF/ml (t)hor1 /m-
angiotensin I re() for the indicated times at 37aC in the presence of
10 mm-LiCI. Following termination of the reaction, samples were
assayed for the accumulation of [eH]inositol phosphates by anion-
exchange chromatography. For comparative purposes, the data are
presented as the percentage of accumulation at the earliest time of
maximal response for angiotensin II (i.e. 30 s) and EGF (i.e. 7 min).
The maximal EGF response typically represented 40-60% of the
maximal angiotensin II response. The data are pooled results from
four and three separate experiments with EGF and angiotensin II
respectively.
RESULTS
We have previously demonstrated that exposure of intact WB
cells to EGF, adrenaline, angiotensin II or [Arg8]vasopressin
results in an increase in the cellular levels of InsPj, InsP2 and
InsP3 (Hepler et al., 1988; Earp et al., 1988). Experiments were
carried out to determine the comparative time courses for
accumulation of inositol phosphates in response to EGF or
angiotensin II in WB cells. Consistent with previous findings
(Hepler et al., 1988), angiotensin II stimulated a very rapid
accumulation of inositol phosphates that reached a maximum
within 30 s (Fig. 1). The rapid termination of this response is
apparently due to a protein kinase C-mediated agonist-induced
desensitization ofthe receptor-regulated phospholipase C (Hepler
et al., 1988). In contrast, the rate of accumulation of inositol
phosphates in response to EGF was considerably slower than
that for angiotensin II (Fig. 1). After addition of EGF, a brief lag
period (approx. 30 s) was observed before increased levels of
inositol phosphates were detected (Fig. 1, inset). Inositol
phosphates then continued to accumulate until maximal levels
were attained by approx. 7-8 min. Using h.p.l.c. analysis, we
have shown previously that exposure to angiotensin II stimulates
the rapid, albeit transient, accumulation of Ins(1,4,5)P3 and
Ins(1,3,4)P3 in WB cells (Hepler et al., 1988). EGF also stimulates
an accumulation of metabolic products of Ins(1,4,5)P3 in WB
cells, although increases in radioactive products only occur after
periods of growth factor exposure greater than 30 s (results not
shown). The relative difference in the time courses of inositol
phosphate accumulation in response to angiotensin II and EGF
was not abolished by chelation of extracellular Ca2", although in
three experiments EGTA attenuated (0-30% inhibition) the
maximal level of inositol phosphate accumulation observed
(results not shown).
Experiments were carried out to test whether the inositol
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Fig. 2. Additivity of the inositol phosphate response to EGF and hormones
WB cells were incubated overnight with 10 /tM-PMA and 10 ,uCi of
[3H]inositol/ml in inositol-free medium containing 5% fetal calf
serum. Following labelling, cells were treated as follows. (a) Vehicle
(0), EGF (300 ng/mI) (0), 1 /SM-angiotensin 11(A), or angiotensin
II plus EGF (-); (b) vehicle (0), angiotensin II (A), [Arg8J-
vasopressin (0), or angiotensin II plus [Arg8]vasopressin (-) for
the indicated times at 37 °C in the presence of 10 mM-LiCl. On
termination of the reaction, samples were assayed for the
accumulation of [3H]inositol phosphates by anion-exchange
chromatography. The maximal responses to EGF+angiotensin II
(9810+448 c.p.m.; a) and to angiotensin II+[Arg8]vasopressin
(8719+870c.p.m., b) were defined as 100%. The data are the
means + S.E.M. of triplicate determinations and are representative of
three experiments.
EGF and angiotensin II were additive. A meaningful interpret-
ation of data obtained from additivity studies would not be
possible underconditions inwhich agonist-induced desensitization
occurs. This fact presented a problem in WB cells, since we have
previously shown that the inositol phosphate response to
angiotensin II or [Arg8]vasopressin desensitizes rapidly. How-
ever, in cells pretreated overnight with PMA, protein kinase C is
down-regulated, and agonist-induced desensitization of the in-
ositol phosphate response to angiotensin II and [Arg8]vasopressin
no longer occurs (Hepler et al., 1988). Therefore, to determine
whether accumulation of inositol phosphates in response to
maximally effective concentrations of EGF, angiotensin II and
[Arg8]vasopressin was additive, experiments were carried out in
cells pretreated overnight with PMA. EGF and angiotensin II
each stimulated inositol phosphate accumulation, although the
EGF response was smaller and occurred much more slowly than
that for angiotensin II (Fig. 2a). When EGF and angiotensin II
were added simultaneously, inositol phosphates accumulated to
levels equal to or greater than the sum of the responses observed
for angiotensin II and EGF alone. In contrast to EGF,
[Arg8]vasopressin stimulated an accumulation of inositol
phosphates that followed a time course and reached levels
comparable with those stimulated by angiotensin II alone (Fig.
2b). Furthermore, simultaneous addition of these two hormones
resulted in only a small (non-additive) increase in the accumulated
levels of inositol phosphates observed in cells treated with either
hormone alone. Additional studies were carried out to determine
whether the inositol phosphate responses to EGF, angiotensin II
and [Arg8]vasopressin were additive under different experimental
conditions. PKC-depleted WB cells were treated first with a
maximally effective concentration of angiotensin II (I /tM) for
5-20 min, followed by the further addition of angiotensin II,
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Table 1. Guanine nucleotide-dependent stimulation of inositol phosphate
production by hormones but not by EGF in WB cell lysates
Lysates were prepared from [3H]inositol-prelabelled WB cells as
described in the Materials and methods section. Lysates were
incubated at 37 °C for 10 min in the presence of vehicle, the indicated
concentrations ofhormone, EGF or GTP[S], or hormone or EGF in
the presence of GTP[S]. Following termination of the reaction,
samples were assayed for the presence of [3H]inositol phosphates.
All assays were carried out in the presence of 10 mm-LiCl and
300 /sM-GDP[S]. The results are presented as the means+ S.E.M. of
quadruplicate determinations and are representative of two experi-
ments. Statistical significance is indicated as follows. * The increase
in radioactivity due to stimulation by agonist and GTP[S] is
significantly greater than that due to stimulation by GTP[S] alone
(P < 0.01). t The increase in radioactivity due strictly to agonist in
the presence ofGTP[S] [(agonist + GTP[S])-GTP[S]] is significantly
greater (P < 0.01) than that due to agonist alone (agonist-vehicle).
Inositol phosphates
Treatment (c.p.m.)
Vehicle 96 + 26
EGF (300 ng/ml) 159+ 19
Adrenaline (10 ,UM) 140+47
Angiotensin II (1 /M) 189 + 30
[Arg8]Vasopressin (1 /sM) 367 + 18
GTP[S] (100/M) 887+44
GTP[S] (100 ,UM) +EGF (300 ng/ml) 880 + 25
GTP[S] (100 /sM) +adrenaline (1O /SM) 1184±74*t
GTP[S] (100 stM)+angiotensin 1I(1(/M) 1950+66*t
GTP[S] (100/M) + [Arg8]vasopressin (1 /sM) 1966 ±48*t
EGF (300 ng/ml) or [Arg8]vasopressin (I /sM). Under these
conditions, addition of either angiotensin II or [Arg8]vasopressin
did not stimulate a further increase in the levels of inositol
phosphates. In contrast, EGF addition resulted in an increase
(additive with that observed with angiotensin II alone) in the
levels of inositol phosphates identical with that observed in
control cells (results not shown).
Many receptors for hormones and neurotransmitters activate
phospholipase C in a guanine-nucleotide-dependent manner,
suggesting the involvement ofa G-protein in the phosphoinositide
signalling pathway (Martin, 1989; Harden, 1989). Experiments
were carried out to determine the role of guanine nucleotides in
the regulation of EGF- and/or hormone-stimulated activation of
phospholipase C in lysates prepared from [3H]inositol-prelabelled
WB cells. Since it is possible that EGF may activate
phospholipase C by a mechanism requiring the presence of
unknown cytosolic factors, crude lysates prepared with a cocktail
of proteinase inhibitors were used for these experiments. To test
the absolute dependency of the hormone- and EGF-stimulated
responses on exogenously added guanine nucleotides, all assays
were carried out in the presence of guanosine 5'-[L-
thio]diphosphate (GDP[S]) to block the actions of endogenous
GTP. EGF, adrenaline, angiotensin II and [Arg8]vasopressin
each stimulated little or no accumulation of inositol phosphates
when added alone (Table 1). In contrast, addition of GTP[S] (a
non-hydrolysable analogue of GTP) resulted in a large increase
in the levels of inositol phosphates: in the presence of GTP[S],
adrenaline, angiotensin II and [Arg8]vasopressin, but not EGF,
caused an increase in inositol phosphate production greater than
that observed with GTP[S] alone. As illustrated in Fig. 3, EGF
and adrenaline each stimulated a concentration-dependent ac-
cumulation of inositol phosphates in intact WB cells. However,
in crude lysates, neither EGF nor adrenaline alone stimulated

























Fig. 3. Differential stimulation of inositol phosphate accumulation by
adrenaline and EGF in intact WB cells or WB cell lysates
WB cells were labelled overnight with [3H]inositol in inositol-free
medium containing 5 % fetal calf serum. After labelling, cells were
treated with the indicated concentrations of adrenaline (a) or EGF
(b) for 10 min in the presence of 10 mM-LiCl. On termination of the
reaction, cells were assayed for [3H]inositol phosphates by anion-
exchange chromatography. In separate experiments, [3H]inositol-
labelled WB cells were prepared as crude lysates as described in the
Materials and methods section. Lysates were incubated with the
indicated concentrations of adrenaline (c) or EGF (d) in the presence
(@) or absence (0) of 100 /sM-GTP[S] for 10 min at 37 °C in assay
buffer containing 300 /M-GDP[S] and 10 mM-LiCl. On termination
of the reaction, cells were assayed for [3H]inositol phosphates by
anion-exchange chromatography. To more clearly compare the
inositol phosphate responses due to adrenaline and EGF in the
absence or presence ofguanine nucleotide, the increase in [3H]inositol
phosphate due to GTP[S] alone was subtracted from the values
presented.
presence of GTP[S], adrenaline but not EGF was capable of
stimulating inositol phosphate formation in a concentration-
dependent manner. In addition, in digitonin-permeabilized WB
cells, adrenaline and angiotensin II, but not EGF, were capable
of stimulating phospholipase C activity in a guanine nucleotide-
dependent manner (results not shown). Using incubation
conditions identical with those used for observation of guanine
nucleotide-dependent formation of inositol phosphates by
hormones, EGF was capable of binding to and stimulating the
autophosphorylation of its own receptor in both lysates and
permeabilized cells (results not shown). These findings suggest
that the lack of capacity of EGF to activate phospholipase C in
cell-free preparations cannot be explained by a lack of capacity
of EGF to bind to and activate its own receptor.
Johnson & Garrison (1987) reported that pertussis toxin
blocked the accumulation of Ins(1,4,5)P3 and the mobilization of
intracellular Ca2` in response to EGF, but not angiotensin II, in
primary cultures of rat hepatocytes. Overnight pretreatment of
WB cells with concentrations of pertussis toxin up to 1000 ng/ml
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Fig. 4. Lack of effect of pertussis toxin treatment on EGF- or angiotensin II-stimulated inositol phosphate accumulation in WB cells
WB cells were labelled overnight with ['H]inositol in inositol-free medium containing 5 % fetal calf serum in the presence or absence of the
indicated concentrations of pertussis toxin. Following labelling, cells were treated with vehicle (V) or 300 ng of EGF/ml or 1 /ZM-angiotensin II
(ANG II) for 10 min at 37 °C in the presence of 10 mM-LiCl. On termination of the reaction, samples were assayed for the accumulation of
[3H]inositol phosphate by anion-exchange chromatography. The data are pooled results from two experiments performed in triplicate.
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Fig. 5. Pertussis toxin-stimulated I'2PIADP-ribosylation of G; and blockade of guanine nucleotide-mediated inhibition of adenylate cyclase activity
(a) Membranes were prepared from WB cells and treated with 100 ,uM-forskolin in the absence or presence of the indicated concentrations of
GTP[S] (-) or Gpp[NH]p (0) for 10 min at 30 'C. Results are plotted as the percentage of forskolin-stimulated adenylate cyclase activity in the
absence of guanine nucleotide and are representative of two experiments. (b) WB cells were treated overnight with the indicated concentrations
of pertussis toxin (PTX). Membranes were prepared and adenylate cyclase assays were carried out in the presence of forskolin (100 ,uM) or forskolin
plus GTP[S] (10 ,UM). The results are plotted as the percentage of adenylate cyclase activity in the absence of GTP[S] and are representative of two
experiments. (c) Plasma membranes were prepared from cells treated overnight with either vehicle (-) or 300 ng of pertussis toxin/ml (+).
Membranes then were treated with pertussis toxin and ["2P]NAD+ and subjected to SDS/PAGE as described in the Materials and methods section.
An autoradiogram showing molecular masses (kDa) of protein standards is presented.
(Fig. 4a) or to angiotensin II (Fig. 4b). Pertussis toxin treatment
also failed to abolish or attenuate the inositol phosphate
responses to adrenaline and [Arg8]vasopressin (results not
shown). Nevertheless, WB cells apparently do express a func-
tional G, protein, since GTP[S] and guanosine 5'-[/Jy-
imido]triphosphate (Gpp[NH]p) each inhibited forskolin-
stimulated adenylate cyclase activity in a concentration-depen-
dent manner (Fig. 5a). The inability of pertussis toxin to alter
hormone- or growth factor-stimulated inositol phosphate re-
sponse occurred under conditions in which the toxin completely
abolished the guanine nucleotide-mediated inhibition of
forskolin-stimulated adenylate cyclase activity (Fig. 5b), and
where there was apparently complete ADP-ribosylation of a
41 kDa membrane protein, presumably the a-subunit(s) of G,
(Fig. 5c).
It previously has been demonstrated that EGF stimulates
tyrosine phosphorylation of an approx. 150 kDa protein
identified as an isoenzyme of phospholipase C (i.e. phospholipase
C-y) in A431 human epidermoid carcinoma cells (Wahl et al.,
1989a; Nishibe et al., 1989). The effects of EGF and angiotensin
II on the phosphorylation of phospholipase C-y was examined in










































Fig. 6. EGF-stimulated tyrosine phosphorylation of phospholipase C-y in
WB cells
WB cells were treated with vehicle (lane 1), 300 ng of EGF/ml (lane
2), or 1 /sM-angiotensin II (lane 3) for 1 min at 37 °C in Hepes-
buffered Dulbecco's modified Eagle's medium (pH 7.4) as described
in the Materials and methods section. Incubations then were
terminated, cells were collected and samples were solubilized and
immunoprecipitated with anti-(phospholipase C-y) antibodies as
described. Immunoprecipitates were subjected to SDS/PAGE,
transblotted to nitrocellulose, screened for anti-phosphotyrosine
immunoreactivity and visualized using .25I-labelled Protein A and
autoradiography. The mobilities of the EGF receptor (EGFr) and
phospholipase C-y (PLC) are indicated.
I min and then lysed, solubilized and immunoprecipitated with
anti-(phospholipase C-y) antibodies (Suh et al., 1988).
Immunoprecipitates were washed, subjected to SDS/PAGE;
transblotted to nitrocellulose and then screened for phospho-
tyrosine immunoreactivity. EGF markedly stimulated tyrosine
phosphorylation of several proteins, including species with
properties (see the Materials and methods section) consistent
with those of the - 150 kDa phospholipase C-y and the 170 kDa
EGF receptor. In contrast with the effects of EGF on
phosphorylation of phospholipase C-y and the EGF receptor,
angiotensin II did not stimulate tyrosine phosphorylation of
phospholipase C-y during a 1 min incubation (Fig. 6) or with
longer incubation times (results not shown). However, both
EGF and angiotensin II stimulated tyrosine phosphorylation of
an unidentified 93 kDa protein (Fig. 6).
DISCUSSION
The results presented here demonstrate that EGF and
angiotensin II stimulate inositol phosphate accumulation in WB
cells at markedly different rates. The lag associated with ap-
pearance of the EGF response and the clear differences in the
rates of accumulation of inositol phosphates stimulated by EGF
and angiotensin II lend support to the idea that EGF stimulates
phosphoinositide hydrolysis by a pathway distinct from that
utilized by classical hormones. This idea is further supported by
the observation that the inositol phosphate responses to EGF
and angiotensin II are additive whereas the responses to
angiotensin II and [Arg8]vasopressin are not. The more rapid
rate of accumulation of inositol phosphates in response to
angiotensin II suggests a direct link to activation ofphospholipase
C, as might be expected for a hormone receptor that interacts
with a G-protein-activated phospholipase C (Boyer et al., 1989).
In contrast, the lag in activation and the much slower rate of
accumulation of inositol phosphates characteristic of the EGF
response could reflect any of a number of possibilities. For
example, multiple steps could exist between receptor activation
and increased hydrolysis of phosphoinositides.
Cell surface receptors for hormones and neurotransmitters are
apparently coupled to activation of phospholipase C by one or
more as yet unidentified G-proteins (Martin, 1989; Harden,
1989). Guanine-nucleotide-dependent activation of phospho-
lipase C by adrenaline, angiotensin II and [Arg8]vasopressin
in broken-cell preparations from WB cells is consistent with this
idea. In contrast, EGF failed to stimulate phospholipase C
activity in either the presence or the absence of guanine nucleo-
tides, although under these assay conditions EGF was fully
capable of binding to and stimulating autophosphorylation of its
receptor. Thus, if a G-protein is involved in EGF receptor action,
it is not active under assay conditions that support hormone-
receptor and guanine-nucleotide-stimulated activation of phos-
pholipase C. Such a hypothetical G-protein either would be
markedly different from the one involved in linking hormone
receptors to activation of phospholipase C, or perhaps a factor(s)
and/or ancillary protein required for EGF receptor-G-protein
interaction may be non-functional in cell lysates. However, assay
conditions were designed to minimize the latter possibility, and
the simplest explanation is that a G-protein is not involved in
EGF receptor action in WB cells. In support of this conclusion,
several reports (Hasegawa-Sasaki et al., 1988; Cattaneo &
Vincentini, 1989) demonstrated that, in contrast to the situation
with other hormones, PDGF-stimulated phosphoinositide hydro-
lysis in permeabilized fibroblasts is not dependent on the
presence of added GTP or GTP analogues. Similarly, both
studies showed that GDP[S] blocked the actions ofhormones but
not those of PDGF. However, Hasegawa-Sasaki et al. (1988)
reported that GTP[S] apparently inhibited the PDGF response.
These findings suggest that a possible role of a G-protein in
PDGF action (albeit different from that associated with hormone
receptors) cannot be completely ruled out. It should be noted,
however, that Cattaneo & Vincentini (1989) failed to observe a
GTP[S]-mediated inhibition of response to PDGF. The reasons
for this discrepency remain unclear.
Other evidence suggests that the EGF receptor stimulates
phospholipase C by a mechanism that does not involve a G-
protein. Receptors for EGF share little or no amino acid sequence
similarity or predicted structure with the superfamily of G-
protein-linked hormone receptors (Carpenter, 1987; Yarden &
Ullrich, 1988; O'Dowd et al., 1989). Whether amino acid
sequences exist in these growth factor receptors that impart the
capacity to interact with G-protein(s) is not known, although no
direct evidence exists to support this idea. Johnson & Garrison
(1987) have reported that EGF-stimulated Ins(1,4,5)P3 accumu-
lation in rat hepatocytes is abolished by pertussis toxin pre-
treatment, suggesting the possible involvement of a G-protein in
EGF receptor action in rat liver. However, pertussis toxin failed
to alter either EGF- or hormone-stimulated phospholipase C
activity in WB cells. This lack of pertussis toxin sensitivity
occurred at concentrations of toxin that fully ADP-ribosylate
and functionally inactivate G1. It should be noted that WB cells
are liver epithelial cells rather than the parenchymal hepatocytes
studied by Johnson & Garrison (1987). Pike & Eakes (1987) also
reported that EGF-stimulated inositol phosphate formation in
A43 1 cells was not altered by pertussis toxin treatment, and thus
it is possible that pertussis toxin blocks EGF-stimulated acti-
vation of phospholipase C in a cell-specific manner (Milligan,
1988; Martin, 1989). Alternatively pertussis toxin may act at
sites other than receptor-coupled G-proteins in some cell types.
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Consistent with this idea is the observation by Taylor et al.
(1988) that pertussis toxin blocked bombesin-mediated events
in Swiss 3T3 fibroblasts at an unidentified site distal to
receptor-effector coupling.
Most isoenzymes of phospholipase C are activated, at least in
vitro, by micromolar concentrations of Ca2+, and EGF markedly
elevates the cytoplasmic Ca2+ concentration in target tissues
(Wheeler et al., 1987; Hepler et al., 1987; Wahl et al., 1988).
However, although chelation of extracellular Ca2+ attenuated the
maximal accumulation of inositol phosphates in response to
both EGF and hormones, it neither abolished the capacity of
these agents to stimulate phosphoinositide hydrolysis nor altered
the relative time to the maximal response. Thus, elevation of
Ca2+ is not a primary mechanism whereby receptors for EGF (or
hormones) stimulate activation of phospholipase C in WB cells.
These findings are consistent with those of Tilly et al. (1988) who
reported that the EGF-stimulated accumulation of inositol
phosphates in A43 1 cells occurred more slowly than that caused
by bradykinin, that the EGF response was additive to bradykinin
stimulation, and that these responses did not require extracellular
Ca2+
Receptors for EGF are fundamentally different from G-
protein-linked hormone receptors in another important respect,
in that they express intrinsic tyrosine-specific protein kinase
activity. What role, if any, the tyrosine kinase activity associated
with the EGF receptor subserves in regulation of phospholipase
C activity is not clear. Chen et al. (1987) and Moolenaar et al.
(1988) demonstrated that inactivation of the EGF receptor
kinase by site-directed mutagenesis abolished a variety of
transmembrane signalling events associated with EGF receptor
action, including the rapid release of cytoplasmic Ca2+ from
intracellular stores [presumably mediated by Ins(1,4,5)P3]. More
recently, Wahl et al. (1988) have demonstrated that, following
stimulation of EGF receptors on A431 cells, phospholipase C
activity was recovered from soluble cell extracts by anti-
phosphotyrosine antibody affinity chromatography. The
phosphorylated phospholipase C was later identified as the
- 150 kDa enzyme termed phospholipase C-y by Rhee and co-
workers (Ryu et al., 1987; Rhee et al., 1989), since monoclonal
antibodies that recognize this phospholipase C (Suh et al., 1988)
precipitated tyrosine-phosphorylated protein from EGF-treated
cells (Wahl et al., 1989a). The present findings demonstrate that
EGF-stimulated accumulation of inositol phosphates in intact
WB cells is correlated with its capacity to stimulate the tyrosine
phosphorylation of phospholipase C-y, whereas the even more
marked accumulation of inositol phosphates in the presence of
angiotensin II occurs with no tyrosine phosphorylation of
phospholipase C-y. Thus there is no GTP-dependence of the
effects of EGF in WB cells, and EGF-dependent regulation of
phospholipase C occurs potentially as a result of receptor-
stimulated tyrosine phosphorylation of phospholipase C-y.
Interestingly both EGF and angiotensin II stimulated
phosphorylation of an approx. 93 kDa protein (Fig. 6; W. R.
Huckle, unpublished work). Although the identity and function
of this protein remain unknown, a possible role for this species,
either direct or indirect, in the regulation of phospholipase C
activity cannot be ruled out by the present data. The findings
presented here with WB cells also demonstrate that, as is the
case with A431 cells (Wahl et al., 1989a), EGF receptors (and
several other unidentified proteins) are co-precipitated by anti-
(phospholipase C-y) antibodies. These observations raise the
possibility that these proteins may be functionally linked in a
multi-component complex.
Although the complete amino acid sequences of at least five
distinct proteins with phospholipase C-like activity have been
reported (Rhee et al., 1989), the identity of the isoenzyme(s)
regulated by receptors and G-proteins is not yet known. EGF
receptors stimulate tyrosine phosphorylation of phospholipase
C-y, but whether this phosphorylation event leads to a direct
alteration of enzyme activity has not yet been demonstrated.
Whether EGF receptors and G-protein-linked hormone receptors
activate the same, different or overlapping phospholipase C
isoenzymes also remains an important unresolved question. The
present findings suggest that EGF receptors and non-tyrosine-
kinase hormone receptors each possess the capacity to stimulate
phospholipase(s) C activity in WB cells, but this apparently
occurs by separate pathways.
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